๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Polarized Light Therapy for Radiation Dermatitis in Breast Cancer

RecruitingNAAges 35 Years - 55 YearsFemaleBeni-Suef University
NCT07600957 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast cancer undergoing hypofractionated whole-breast radiotherapy. Participants will be randomly allocated to receive either standard skin care alone or standard care combined with polarized light therapy initiated from the first radiotherapy session. Outcomes will include objective ultrasound-based dermal thickness measurements, clinical severity of radiation dermatitis using Radiation Therapy Oncology Group (RTOG) criteria.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Female patients aged 35-55 years. 2. Histologically confirmed primary unilateral breast cancer. 3. Status post breast-conserving surgery (lumpectomy). 4. Planned for hypo fractionated whole-breast irradiation (HFWBI). 5. Scheduled to receive a total radiation dose of 40-42.5 Gy delivered in 15-16 fractions over approximately 3 weeks. 6. Ability to understand study procedures and provide written informed consent. Exclusion Criteria: 1. Previous radiotherapy to the same breast or thoracic region. 2. Bilateral breast cancer. 3. Metastatic or advanced systemic disease. 4. Prior mastectomy. 5. Active skin infection in the irradiated area. 6. Pre-existing dermatologic disorders affecting the breast skin (e.g., eczema, psoriasis, dermatitis). 7. Concurrent chemotherapy during radiotherapy. 8. Presence of cardiac pacemaker or implantable electronic device in the treatment field. 9. Open wounds or ulceration in the irradiated breast region. 10. Any medical condition judged by the investigator to interfere with study participation or outcome assessment.
๐Ÿ’Š

What it tests

  • Polarized Polychromatic Light Therapy
  • Standard Skin Care
๐Ÿ“

Where

1 site
Out patient clinic , faculty of Physical Therapy, Beni Sueif university
Banฤซ Suwayf, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy